• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工瓣膜与患者不匹配对二尖瓣置换术后生存率的影响。

Impact of prosthesis-patient mismatch on survival after mitral valve replacement.

作者信息

Magne Julien, Mathieu Patrick, Dumesnil Jean G, Tanné David, Dagenais François, Doyle Daniel, Pibarot Philippe

机构信息

Laval Hospital Research Center/Québec Heart Institute, Faculty of Medicine, Laval University, Québec, Canada.

出版信息

Circulation. 2007 Mar 20;115(11):1417-25. doi: 10.1161/CIRCULATIONAHA.106.631549. Epub 2007 Mar 5.

DOI:10.1161/CIRCULATIONAHA.106.631549
PMID:17339554
Abstract

BACKGROUND

We recently reported that valve prosthesis-patient mismatch (PPM) is associated with persisting pulmonary hypertension after mitral valve replacement. Thus, the objective of this study was to evaluate the impact of PPM on mortality in patients undergoing mitral valve replacement.

METHODS AND RESULTS

The indexed valve effective orifice area was estimated for each type and size of prosthesis being implanted in 929 consecutive patients and used to define PPM as not clinically significant if > 1.2 cm2/m2, as moderate if > 0.9 and < or = 1.2 cm2/m2, and as severe if < or = 0.9 cm2/m2. Moderate PPM was present in 69% of patients; severe PPM was seen in 9%. For patients with severe PPM, 6-year survival (74+/-5%) and 12-year survival (63+/-7%) were significantly less than for patients with moderate PPM (84+/-1% and 76+/-2%; P=0.027) or nonsignificant PPM (90+/-2% and 82+/-4%; P=0.002). On multivariate analysis, severe PPM was associated with higher mortality (hazard ratio, 3.2; 95% confidence interval, 1.5 to 6.8; P=0.003).

CONCLUSIONS

Severe PPM is an independent predictor of mortality after mitral valve replacement. As opposed to other independent risk factors, PPM may be avoided or its severity may be reduced with the use of a prospective strategy at the time of operation. For patients identified as being at risk for severe PPM, every effort should be made to implant a prosthesis with a larger effective orifice area.

摘要

背景

我们最近报道,瓣膜假体-患者不匹配(PPM)与二尖瓣置换术后持续存在的肺动脉高压有关。因此,本研究的目的是评估PPM对二尖瓣置换患者死亡率的影响。

方法与结果

对929例连续患者植入的每种类型和尺寸的假体估计其指数化瓣膜有效开口面积,若>1.2 cm²/m²则定义PPM为无临床意义,若>0.9且≤1.2 cm²/m²则为中度,若≤0.9 cm²/m²则为重度。69%的患者存在中度PPM;9%的患者存在重度PPM。重度PPM患者的6年生存率(74±5%)和12年生存率(63±7%)显著低于中度PPM患者(84±1%和76±2%;P=0.027)或无显著PPM患者(90±2%和82±4%;P=0.002)。多因素分析显示,重度PPM与较高的死亡率相关(风险比,3.2;95%置信区间,1.5至6.8;P=0.003)。

结论

重度PPM是二尖瓣置换术后死亡率的独立预测因素。与其他独立危险因素不同,PPM可通过手术时采用前瞻性策略避免或降低其严重程度。对于被确定有重度PPM风险的患者,应尽一切努力植入有效开口面积更大的假体。

相似文献

1
Impact of prosthesis-patient mismatch on survival after mitral valve replacement.人工瓣膜与患者不匹配对二尖瓣置换术后生存率的影响。
Circulation. 2007 Mar 20;115(11):1417-25. doi: 10.1161/CIRCULATIONAHA.106.631549. Epub 2007 Mar 5.
2
Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor® porcine prosthetic valves.接受二尖瓣Biocor®猪生物瓣膜置换的患者中人工瓣膜-患者不匹配的发生率。
Cardiol J. 2016;23(2):178-83. doi: 10.5603/CJ.a2016.0011. Epub 2016 Feb 15.
3
The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement.人工瓣膜与患者不匹配对二尖瓣置换术后远期结局的影响。
J Thorac Cardiovasc Surg. 2007 Jun;133(6):1464-73. doi: 10.1016/j.jtcvs.2006.12.071. Epub 2007 Apr 27.
4
Effect of prosthesis patient mismatch in mitral position on pulmonary hypertension.二尖瓣位置假体患者不匹配对肺动脉高压的影响。
Eur J Cardiothorac Surg. 2017 Dec 1;52(6):1168-1174. doi: 10.1093/ejcts/ezx167.
5
Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement.人工瓣膜-患者不匹配对主动脉瓣置换术后短期死亡率的影响。
Circulation. 2003 Aug 26;108(8):983-8. doi: 10.1161/01.CIR.0000085167.67105.32. Epub 2003 Aug 11.
6
Impact of prosthesis-patient mismatch on long-term survival in patients with small St Jude Medical mechanical prostheses in the aortic position.主动脉位置植入小型圣犹达医疗机械瓣膜的患者中,人工瓣膜-患者不匹配对长期生存的影响。
Circulation. 2006 Jan 24;113(3):420-6. doi: 10.1161/CIRCULATIONAHA.105.546754. Epub 2006 Jan 16.
7
Impact of prosthesis-patient mismatch on cardiac events and midterm mortality after aortic valve replacement in patients with pure aortic stenosis.
Circulation. 2006 Jan 31;113(4):570-6. doi: 10.1161/CIRCULATIONAHA.105.587022. Epub 2006 Jan 9.
8
Impact of prosthesis-patient mismatch on tricuspid valve regurgitation and pulmonary hypertension following mitral valve replacement.人工瓣膜与患者不匹配对二尖瓣置换术后三尖瓣反流和肺动脉高压的影响。
Int J Cardiol. 2013 Oct 9;168(4):4150-4. doi: 10.1016/j.ijcard.2013.07.116. Epub 2013 Aug 7.
9
Impact of prosthesis-patient mismatch after mitral valve replacement in rheumatic population: Does mitral position prosthesis-patient mismatch really exist?风湿性二尖瓣置换术后人工瓣膜与患者不匹配的影响:二尖瓣位人工瓣膜与患者不匹配真的存在吗?
J Cardiothorac Surg. 2017 Oct 10;12(1):88. doi: 10.1186/s13019-017-0653-x.
10
Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement.人工瓣膜-患者不匹配对二尖瓣置换术后肺动脉压的影响。
J Am Coll Cardiol. 2005 Apr 5;45(7):1034-40. doi: 10.1016/j.jacc.2004.10.073.

引用本文的文献

1
Left Atrial to Left Ventricular Bypass Using a Valved Conduit for Mitral Prosthesis-Patient Mismatch.使用带瓣管道进行左心房至左心室旁路手术治疗二尖瓣人工瓣膜-患者不匹配
Ann Thorac Surg Short Rep. 2023 Jun 26;1(4):647-649. doi: 10.1016/j.atssr.2023.06.002. eCollection 2023 Dec.
2
Together Toward Patient-Oriented Solutions: The True Spirit of the Heart Team.携手迈向以患者为导向的解决方案:心脏团队的真正精神。
JACC Case Rep. 2024 Nov 6;29(21):102707. doi: 10.1016/j.jaccas.2024.102707.
3
Intravenous Levosimendan versus Inhalational Milrinone in the Management of Pulmonary Hypertension during Adult Cardiac Surgery: A Randomized Clinical Trial.
成人心脏手术期间静脉注射左西孟旦与吸入米力农治疗肺动脉高压的随机临床试验
Life (Basel). 2024 Sep 14;14(9):1164. doi: 10.3390/life14091164.
4
Monitoring of Levosimendan Administration in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery and Effect of Two Different Dosing Schemes on Hemodynamic and Echocardiographic Parameters.心脏手术患者肺动脉高压患者中左西孟旦给药的监测以及两种不同给药方案对血流动力学和超声心动图参数的影响。
Pharmaceuticals (Basel). 2023 May 30;16(6):815. doi: 10.3390/ph16060815.
5
Pulmonary Hypertension in Heart Failure.心力衰竭中的肺动脉高压
Int J Heart Fail. 2021 Apr 21;3(3):147-159. doi: 10.36628/ijhf.2020.0053. eCollection 2021 Jul.
6
Hybrid Surgery for Severe Mitral Valve Calcification: Limitations and Caveats for an Open Transcatheter Approach.杂交手术治疗重度二尖瓣钙化:经导管开放手术入路的局限性和注意事项。
Medicina (Kaunas). 2022 Jan 7;58(1):93. doi: 10.3390/medicina58010093.
7
Computational investigation of left ventricular hemodynamics following bioprosthetic aortic and mitral valve replacement.生物人工主动脉瓣和二尖瓣置换术后左心室血流动力学的计算研究
Mech Res Commun. 2021 Mar;112. doi: 10.1016/j.mechrescom.2020.103604. Epub 2020 Oct 16.
8
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival.瓣膜性心脏病校正后持续性肺动脉高压:血流动力学见解和长期生存。
J Am Heart Assoc. 2021 Jan 19;10(2):e019949. doi: 10.1161/JAHA.120.019949. Epub 2021 Jan 5.
9
Prosthesis-patient mismatch after mitral valve replacement: A pooled meta-analysis of Kaplan-Meier-derived individual patient data.二尖瓣置换术后人工瓣膜-患者不匹配:基于Kaplan-Meier法的个体患者数据的汇总Meta分析。
J Card Surg. 2020 Dec;35(12):3477-3485. doi: 10.1111/jocs.15108. Epub 2020 Oct 21.
10
Weight gain potential-a neglected entity during valve replacement.体重增加潜力——瓣膜置换过程中一个被忽视的因素。
Indian J Thorac Cardiovasc Surg. 2020 Jan;36(1):21-27. doi: 10.1007/s12055-019-00838-7. Epub 2019 Jul 19.